Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Qinbaiqingfei Nongsuowan versus azithromycin in pediatric Mycoplasma pneumoniae pneumonia
CTR20230460Phase 3Active
- Sponsor
- Heilongjiang Provincial Academy of Traditional Chinese Medicine
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of qinbaiqingfei nongsuowan in Mycoplasmal pneumonia, sponsored by Heilongjiang Provincial Academy of Traditional Chinese Medicine. Started Oct 2023; status: active.
02
Drugs
qinbaiqingfei nongsuowan
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on CTR20230460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230460.